Burning Rock Biotech Ltd (BNR)
8.03
-0.20
(-2.43%)
USD |
NASDAQ |
May 16, 16:00
8.20
+0.17
(+2.12%)
After-Hours: 20:00
Burning Rock Biotech Gross Profit Margin (Quarterly): 64.51% for Dec. 31, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 64.51% |
| September 30, 2023 | 67.35% |
| June 30, 2023 | 68.66% |
| March 31, 2023 | 69.31% |
| December 31, 2022 | 71.19% |
| September 30, 2022 | 70.23% |
| June 30, 2022 | 63.13% |
| March 31, 2022 | 64.62% |
| December 31, 2021 | 71.52% |
| September 30, 2021 | 72.34% |
| Date | Value |
|---|---|
| June 30, 2021 | 70.89% |
| March 31, 2021 | 72.16% |
| December 31, 2020 | 75.27% |
| September 30, 2020 | 73.93% |
| June 30, 2020 | 73.29% |
| March 31, 2020 | 66.52% |
| December 31, 2019 | 62.00% |
| September 30, 2019 | 75.38% |
| June 30, 2019 | 73.17% |
| March 31, 2019 | 74.77% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
62.00%
Minimum
Dec 2019
75.38%
Maximum
Sep 2019
69.76%
Average
70.89%
Median
Jun 2021
Gross Profit Margin (Quarterly) Benchmarks
| Sinovac Biotech Ltd | -- |
| CASI Pharmaceuticals Inc | 59.05% |
| Zai Lab Ltd | 61.42% |
| Gracell Biotechnologies Inc (DELISTED) | -- |
| Adagene Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -68.03% |
| Return on Assets | -49.94% |
| Return on Invested Capital | -68.03% |
| Profit Margin (Quarterly) | -134.0% |
| Operating Margin (Quarterly) | -137.4% |
| Return on Net Operating Assets | -126.6% |